Occuli dextra proptosis in symptomatic hiperthyroidism with diffuse goitre in 45 year old woman: A case report with literature review

Timotius Timotius(1), Ananda Putra(2), Johansen Johansen(3), Pussof Yayazucah Titanic(4), Diana Novitasari(5*)
(1) Faculty of Medicine Tarumanagara University, Jakarta, Indonesia
(2) Medical Professional Program, Faculty of Medicine Tarumanagara University, Jakarta
(3) Medical Professional Program, Faculty of Medicine Tarumanagara University, Jakarta
(4) Medical Professional Program, Faculty of Medicine Tarumanagara University, Jakarta
(5) Department of Internal Medicine KRMT Wongsonegoro General Hospital, Semarang
(*) Corresponding Author
DOI : 10.30604/jika.v8i3.2450


Hyperthyroid is refers to increased of thyroid synthesis hormon production by the thyroid gland that cause an excessive amount thyroid homrone circulate in the blood and eventually cause protrusion of unilateral or both eyes at the anterior out of the orbit due to an increased orbital content within the rigid bony orbit. We report the case of 45 -year-old woman with major complaints of blurred vision on her right eye. Blurred vision on this patient is without a red eye but have a tension on his eye that feel like going out. On local examination of the neck area, there was visible mass during inspection, and on palpation there mass in the neck area. On laboratory examination, TSHs levels were 0.085 uIU/mL, FT4 levels were 12.8 pmol/L, creatinine was 0.9 mg/dL, Calcium was 1.23 mmol/L, Natrium 134 mmol/L, Kalium 3.30 mmol/L. On Colli ultrasound, multiple lymphadenopathy were found on the right and left Colli measuring 1.65 cm x 0.6 cm in the right Colli and 2.10 cm x 0.35 cm in the left Colli and on Head CT-scan with contrast orbita centration, Brain edema and proptosis on occuli dextra were found. The patient underwent oral therapy using propylthiouracil and intravenous methylprednisolone therapy. Administered intravenous methylprednisolone pulse therapy show a significant decrease on grave opthalmopathy severity.


occuli dextra proptosis; symptomatic hyperthyroidism; diffuse goitre


De Leo, S., Lee, S. Y., & Braverman, L. E. (2016). Hyperthyroidism. The Lancet, 388(10047), 906–918.

Fatourechi, V. (2012). Thyroid dermopathy and acropachy. Best Practice & Research Clinical Endocrinology & Metabolism, 26(4), 553–565.

Huang, Y., Fang, S., Zhang, S., & Zhou, H. (2020). Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development. Taiwan Journal of Ophthalmology, 10(3), 174.

Huh, J., Park, S. J., & Lee, J. K. (2020). Measurement of proptosis using computed tomography based three-dimensional reconstruction software in patients with Graves’ orbitopathy. Scientific Reports, 10(1), 14554.

Khan, R., Sikanderkhel, S., Gui, J., Adeniyi, A.-R., O’Dell, K., Erickson, M., Malpartida, J., Mufti, Z., Khan, T., & Mufti, H. (2020). Thyroid and cardiovascular disease: a focused review on the impact of hyperthyroidism in heart failure. Cardiology Research, 11(2), 68.

?acheta, D., Mi?kiewicz, P., G?uszko, A., Nowicka, G., Struga, M., Kantor, I., Po?lednik, K. B., Mirza, S., & Szczepa?ski, M. J. (2019). Immunological aspects of Graves’ ophthalmopathy. BioMed Research International, 2019.

Le Moli, R., Malandrino, P., Russo, M., Lo Giudice, F., Frasca, F., Belfiore, A., & Vigneri, R. (2020). Corticosteroid Pulse Therapy for Graves’ Ophthalmopathy Reduces the Relapse Rate of Graves’ Hyperthyroidism. Frontiers in Endocrinology, 11, 367.

Li, X., Li, S., Fan, W., Rokohl, A. C., Ju, S., Ju, X., Guo, Y., & Heindl, L. M. (2023). Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review. International Ophthalmology, 43(4), 1437–1449.

Lin, J.-D., Yang, S.-F., Wang, Y.-H., Fang, W.-F., Lin, Y.-C., Liou, B.-C., Lin, Y.-F., Tang, K.-T., & Cheng, C.-W. (2017). Associations of melatonin receptor gene polymorphisms with Graves’ disease. PLoS One, 12(9), e0185529.

Malik, I., & Wadhwa, R. (2016). Percutaneous nephrolithotomy: current clinical opinions and anesthesiologists perspective. Anesthesiology Research and Practice, 2016.

Piantanida, E. (2017). Preoperative management in patients with Graves’ disease. Gland Surgery, 6(5), 476.

Rago, T., & Vitti, P. (2022). Risk stratification of thyroid nodules: From ultrasound features to TIRADS. Cancers, 14(3), 717.

?ahl?, E., & Gündüz, K. (2017). Thyroid-associated ophthalmopathy. Turkish Journal of Ophthalmology, 47(2), 94.

Sajjadi-Jazi, S. M., Sharifi, F., Varmaghani, M., Meybodi, H. A., Farzadfar, F., & Larijani, B. (2018). Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis. Journal of Diabetes & Metabolic Disorders, 17, 345–355.

Smith, T. J., & Hegedüs, L. (2016). Graves’ disease. New England Journal of Medicine, 375(16), 1552–1565.

Wiersinga, W. M., Perros, P., Kahaly, G. J., Mourits, M. P., Baldeschi, L., Boboridis, K., Boschi, A., Dickinson, A. J., Kendall-Taylor, P., & Krassas, G. E. (2006). Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers. European Journal of Endocrinology, 155(3), 387–389.

Yang, I.-H., Rose, G. E., Ezra, D. G., & Bailly, M. (2019). Macrophages promote a profibrotic phenotype in orbital fibroblasts through increased hyaluronic acid production and cell contractility. Scientific Reports, 9(1), 9622.

Article Statistic

Abstract view : 127 times
PDF (Bahasa Indonesia) views : 99 times

Dimensions Metrics

How To Cite This :


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.